Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daisuke Kato
Observed name:
DAISUKE KATO
Institutions:
Japanese Red Cross Nagoya Daini Hospital,
Nurix (United States)
Observed institutions:
Mie University,
Otsu Red Cross Hospital,
Japanese Red Cross Nagoya Daini Hospital,
Nurix (United States),
Nagoya University
ORCID:
0009-0000-1767-2389
Observed ORCID:
0009-0000-1767-2389
OpenAlex ID:
A5109237904
Successful treatment of two consecutive cases of pulmonary pleomorphic carcinoma with platinum chemotherapy
2015
·
DAISUKE KATO
, YUICHI CHIHARA
, et al.
·
Oncology Letters
·
12
PDF
Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis
2025
·
Takanori Suzuki
, Kentaro Matsuura
, et al.
·
Hepatology Research
·
10
Abstract 3423: NX-2127: A first-in-class clinical stage degrader of BTK and IKZF1/3 for the treatment of patients with B cell malignancies
2023
·
Jeffrey T. Mihalic
, Nivetha Brathaban
, et al.
·
Cancer Research
·
6
Targeted Protein Degradation of BTK As a Unique Therapeutic Approach for B Cell Malignancies
2019
·
Aileen Kelly
, Daniel W Robbins
, et al.
·
Blood
·
4
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation
2022
·
Takanori Suzuki
, Kentaro Matsuura
, et al.
·
Hepatology Research
·
3
PDF
Abstract 3983: Direct contact of heterogeneous fibroblasts with cancer cells regulates the invasive phenotype of prostate cancer cells
2020
·
Kenichiro Ishii
, Yasuhisa Nakagawa
, et al.
·
Cancer Research
·
3
Bexobrutideg: A Selective, Catalytic Degrader of Bruton’s Tyrosine Kinase Overcomes Inhibitor Resistance and Suppresses Autoantibody-Mediated Disease
2026
·
Mark Noviski
, Paul Auger
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysis
2026
·
Takanori Suzuki
, Kentaro Matsuura
, et al.
·
International Journal of Clinical Oncology
The Initial Therapeutic Response in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Contributes to the Change of Liver Function during Treatment: A Multicenter Analysis
2026
·
Takanori Suzuki
, Ryo Sato
, et al.
·
Oncology
Abstract 1768: Real time in vivo imaging of brain metastasis visualized dynamic reaction of microglia against cancer cells
2021
·
Takahiro Tsuji
, Hiroaki Wake
, et al.
·
Cancer Research
Abstract 380: The quantified immune response against brain metastasis of lung cancer in vivo
2020
·
Mariko Shindo
, Takahiro Tsuji
, et al.
·
Cancer Research
Show more works
View as search
Works count:
11
Citation count:
39
H-index:
4
I10-index:
2
Year
Topic
Type